Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion by unknown
Brief DetlnRive  Report 
Normal T  Lymphocytes Can Express Two Different 
T  Cell Receptor/3 Chains:  Implications for the 
Mechanism  of Allelic Exclusion 
By Elisabetta Padovan, Claudia Giachino, Marina Cella, 
Salvatore Valitutti, Oreste Acuto,* and Antonio Lanzavecchia 
From the Basel Institute  for Immunology, CH-4005 Basel, Switzerland; and *Molecular 
Immunology Unit, Pasteur Institute, 75724, Paris, France 
Suml~ary 
We have examined the extent of allelic exclusion at the T  cell receptor (TCR)/5  locus using 
monoclonal antibodies specific for V/5 products. A small proportion (~ 1%) of human peripheral 
blood T cells express two V/5 as determined by flow cytometric analysis, isolation of representative 
clones, and sequencing of the corresponding V/5 chains.  Dual/5 T cells are present in both the 
CD45R0 + and CD45R0-  subset. These results indicate that dual/5 expression is compatible 
with both central and peripheral selection. They also suggest that the substantial degree of TCRq8 
allelic exclusion is dependent only on asynchronous rearrangements at the/5 locus, whereas the 
role of the pre-TCR is limited to signaling the presence of at least one functional/5 protein. 
D 
NA rearrangements mediating assembly of/5 and ot chain 
genes of the TCR. are developmentally ordered (1-3). 
T cells developing along the or//5 lineage rearrange the/5 locus 
first, and, when a functional/5 chain gene is generated, ex- 
press  its product on the cell surface in association with an 
invariant component constituting a pre-TCR (4). Signaling 
via this pre-TCR requires the tyrosine kinase lck (5) and results 
in: (a) arrest of rearrangements at the/5 locus, a process re- 
ferred to as allelic exclusion; (b) thymocyte expansion and 
maturation to the double positive stage;  and (c) initiation 
of rearrangements at the ot locus (6-8). There are no reasons, 
a priori, to think that this mechanism may prevent matura- 
tion of T cells in which both/5 alleles may have productively 
rearranged. Therefore T  cells with two/5 chains should be 
present at low frequency in the T cell repertoire, unless specific 
mechanisms exist to prevent simultaneous/5 rearrangement 
or to abort cells with two/5-chains. 
So far, all T cell clones analyzed express only one in-frame 
rearranged/5, whereas the other chromosome carries either 
a partial DJ or an out-of-frame rearrangement (2). The only 
exception reported is that of a tetraploid clone that carries 
two productively rearranged V/5 (9). These findings supported 
the notion that a complete allelic exclusion at the/5 locus 
is achieved  at the genotypic level. 
We have previously documented the existence of rare human 
T cell clones with two in-frame/5 chain mRNAs expressed 
at apparently different levels (10 and Acuto, O., unpublished 
observations). Trivial explanations such as cell contamination 
were excluded, as only one functional o~ chain mRNA could 
be identified, suggesting that dual/5 expressing T cells may 
indeed exist. 
Using mAbs that recognise V/5 gene products we have ex- 
amined the surface expression of TCR-/5 in peripheral blood 
T  cells.  Dual/5  expressing cells were found at  a low but 
significant frequency ("~1%). Isolation of T cell clones and 
sequencing of their V/5 gene segments confirmed that both 
V/5 gene products are part of two functional TCRs. 
The implications of these exceptions for the mechanism 
of allelic exclusion are discussed. 
Materials and Methods 
Antibodies and FACS Staining.  The following mouse mAbs to 
human VB were a generous gift of Dr. A. Necker (Immunotech, 
Marseille, France): E2.2E7.2 (anti-Vfl2, IgM), LE89 (anti-Vfl3, 
IgG2a), 36213 (anti-VB5.2, IgG1), 3Dll (anti-V/55.3, IgG1), 56C5.2 
(anti-VB8, IgG2a), JU74 (anti-Vf113.3, IgG1), E17.5F3 (anti-Vf117, 
IgG1), 417.5F3 (anti-Vf119, IgG1), and IMMU546  (anti-VB22, 
IgG1). mAb C21 (anti-Villi,  IgG2a) was produced in our labora- 
tory (11). As second antibodies we used PE-labeled goat anti-mouse 
IgM and FITC-labeled goat anti-mouse IgG1 or IgG2a (Southern 
Biotechnology  Associates,  Birmingham, AL). In three-color  staining 
experiments, biotin-labeled  WT31 (anti-human CD3, IgG1; Becton 
Dickinson & Co., Mountain View, CA) followed by streptavidin- 
allophycocyanin  (SAV-APC; SBA) was used to identify T cells. In 
some  experiments  PBMC  were  analyzed  by  four-color  im- 
munofluorescence using  anti-V32  revealed by PE-labeled goat 
anti-mouse IgM, V~19 revealed  by biotin-labeled goat anti-mouse 
IgG1 (SBA)  followed  by APC-SAV, CD3 (clone BMA031, mlgG2b 
FITC-conjugated;  SBA) and CD45R0  (clone UCHL1,  IgG2a, 
American Type Culture Collection, Rockville, MD) revealed by 
Texas red (TXRD)-conjugated goat  anti-mouse IgG2a (SBA). 
Stained cells were analyzed by flow cytometry on a FACStar Plus  | 
(Becton Dickinson & Co.) using the LYSYS II software. Propidium 
Iodide (PI) was added to gate out dead cells. 
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were separated and expanded in polyclonal  cell lines using 1/xg/ml 
PHA (Wellcome, Beckenham, UK) and aUogeneic 3,000 rad ir- 
radiated mononuclear cells and subsequently cloned  by limiting di- 
lution (12). Briefly, sorted cells were cloned at 0.3 cells per well 
in Terasaki plates in  the presence of irradiated PBMC (0.5  x 
106/ml) in medium RPMI-5%  human serum (Swiss Red Cross, 
Bern, Switzerland) containing 1 #g/ml PHA and Ib2 400 U/ml. 
T ceils  clones  were expanded  in medium supplemented  with human 
serum and II.-2. 
RT-PCR and Direct Sequencing of V~ Chains.  Total  RNA was 
extracted from 2  x  106 T cells as described (13) and reverse tran- 
scribed using oligo d(T) as primer and avian myeloblastosis  virus 
reverse transcriptase (Promega Corp., Madison, WI) in 30-/~1 final 
volume, cDNA (1.5 Ixl) was PCR amplified  in a Perkin-Elmer  9600 
Thermocycler (Cetus, Emeryville, CA) using the following oligo- 
nucleotides: Vfl2 5'-TCATCAACCATGCAAGCCTGACCT;  V/33 
5'-GTCTCTAGAGAGAAGAAGGACCGC; Vfl5 5'-TTCCCT- 
AACTATAGCTCTGAGCTG; Vfl8 5'-ATTTACTTTAACAAG- 
GTTCCG  in association with a primer complementary to the 
constant region C/~1 5'-TGCTGACCCCACTGTCGACCTCCT- 
TCCCATT. The PC1K profile was the following: 2 rain at 94~ 
followed by 30 cycles at 94~  for 15 s, 60~  for 20 s, 72~  for 
35 s, followed  by a final 10-min extension. The amplification  prod- 
ucts were electrophoresed through  a 0.7% NuSieve (FMC Bio- 
Products, Rockland, ME). The bands were excised from the gel, 
melted at 65~  and directly sequenced by the cycle sequencing 
method (Sequitherm; Epicenter  Technol.,  Madison, WI) according 
to the manufacturer's instructions with an internal Cfl oligonucle- 
otide C~II 5'-TGCTTCTGATGGCTCAA. 
T Cell Proliferation.  T cells (2  x  104) were cultured with an 
equal number of 6,000 rad irradiated allogeneic  EBV-B cells in 200 
/~1 RPMI-10% FCS in the presence or absence of different concen- 
trations of bacterial toxins staphylococcal  enterotoxin E (SEE) and 
toxic shock syndrome toxin. Thymidine incorporation was mea- 
sured after 48 h. 
Results 
T Cells Expressing Two V~ Are Present in Human Peripheral 
Blood.  Using antibodies to different Vcr  products we have 
recently shown that up to 30% of human peripheral blood 
T cells carry two Vor as part of two functional and indepen- 
dent TCRs (14). To examine the extent of allelic exclusion 
at the ~ locus we performed similar experiments using a panel 
of anti-VB mAbs. 
In a series of experiments, PBMC from healthy donors were 
stained by two-color indirect immunofluorescence with an 
IgM anti-Vfi2 mAb (detected by a PE-labeled goat anti-mouse 
IgM) and a combination of IgG antibodies specific for Vfl3, 
5.2, 5.3, 8, 11, 13.3, 17, 19, and 22 (detected by FITC-labeled 
goat anti-mouse IgG). As shown in Fig. 1 A, a small propor- 
tion of cells (0.05%) was stained by both anti-V~2 as well 
as by additional anti-Vfl mAbs. The double positive cells were 
sorted and expanded in polyclonal cell lines using PHA and 
irradiated feeder cells. Analysis of these cell lines using the 
same antibody combination revealed a much higher frequency 
of cells stained by two anti-Vfl antibodies (Fig.  1/3).  The 
double positive cells were sorted and cloned by limiting dilu- 
tion.  252  dual fl expressing clones were isolated from six 
donors.  Among these,  85%  were CD4 §  whereas the re- 
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Figure  1.  Identification  and cloning  ofT cells  expressing  two V~. (A) 
PBMC stained  with antibodies to Vfl2 (x axis) and Vfl3, 5.2, 5.3, 8, 11, 
13.3, 17, 19 and 22 (V~mix, y axis) the sorting gate and the percentage 
of double positive T cells is shown. (B) Same staining  on the polyclonal 
cell line obtained by in vitro expansion  of the sorted cells. (C-L) Repre- 
sentative clones isolated from sorted cells. 
maining were CD8 + and only two were CD4-8-.  Each 
clone was stained by the Vfl2 specific antibody and by one 
additional VB antibody, either Vfl3, 5.2, 8,  13.3,  19, or 22 
(Fig.  1, C-L and data not shown). The relative  expression 
of the two Vfls varied in different clones, but remained con- 
stant over extended in vitro culture. The unbalanced surface 
expression of the two fl chains may depend on different rates 
of transcription, translation or, most likely, from a preferen- 
tial pairing with the cr  chain (15). 
To confirm by an independent criterion that the clones ex- 
press two different Vfl products, we performed a molecular 
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Clone Ab  Reactivity  V3  N  D  N  J3 
2-5.2-10  V32 vB5.2*  2*  CSAR  HLGQV  QETQYF  2.5* 
5.2  CA  GGVAGDL  DTQYF  2.3 
2-5.2-31  VB2 V35.2  2  CSAR  VCVWGTNFD  GYTF  1.2 
5.2  CASS  LDPGQN  SNQPQHF  1.5 
2-3-33  VB2 VB3  2  CSAR  GSP  EAFF  1.1 
3  CASS  SHPGTPH  YEQYF  2.7 
2-8-12  V32 V38  2  CSA  PGQGVALA  NYGYTF  1.2 
8  CASS  WDRL  NTEAFF  1.1 
2-8-26  V32 V38  2  CS  SGGQTLV  TQYF  2.5 
8  CAS  ISNPQRGAGT  YEQYF  2.7 
* As determined by FACS analysis using antibodies specific for V32, V33, V35.2, and V38. 
*cDNA from the individual clones was amplified  with V- and C-specific  oligonucleotides  and the product was directly  sequenced. V, D, and J seg- 
ments were assigned by comparison  to the published sequences  (16-18). These  sequence data are available from EMBL/GenBank/DDBJ  under acces- 
sion numbers Z48293-Z48302. 
analysis  of the TCR3 mRNA.  cDNA was prepared from 
individual clones and amplified with V- and C-specific oli- 
gonucleotides. In all cases tested, a clear PCR product was 
obtained only with the expected oligonucleotide combina- 
tion. Direct sequencing of the different V3 products gave 
in all cases a single in-frame sequence (Table 1). In different 
clones, the N-region length varied markedly in the two al- 
leles. These results confirm the antibody staining data and 
demonstrate that these clones express two different V3s. 
To rule out the unlikely possibility that dual 3 expressing 
T  cells might be derived from a fusion event between two 
T  cells we measured the total DNA content of the T  cell 
clones by flow cytometric analysis of PI-stained permeabilized 
cells with standard procedures (19). In all cases a diploid DNA 
content was found (data not shown). 
Frequency ofDualfl  T  Cells.  Due to the low frequency 
of dual 3  T  cells, it was di~cult to obtain an accurate esti- 
mate by direct analysis of total PBL. We therefore isolated 
by cell sorting T lymphocytes expressing V32 or V38. These 
cells were expanded in short-term polyclonal lines and ana- 
lyzed by three-color fluorescence for the expression of CD3, 
the original V3, as well as an additional V3. As evident from 
Fig.  2 A,  almost all CD3 § cells were stained by the anti- 
V32 antibody originally used for sorting, whereas a small 
percentage (0.02%) of the cells was stained by both anti V32 
and anti V38 antibodies. If we consider that V38 accounts 
for only 4%  of the V3s expressed in the peripheral blood 
T cells of this donor, we can estimate that the frequency of 
V32 + cells  that  express  any other V3  must  be  •25-fold 
higher, i.e., ~0.5%. The same calculation on the V38 + cell 
line (Fig. 2 B) indicates a frequency of dual 3 T cells of*l%. 
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Figure  2.  Frequency  of dual 3 T cells in polyclonal  T cell lines. V32 + 
and V38 + T cells were sorted from peripheral  blood and expanded  into 
polyclonal  cell  lines. After  2 wk of  culture  the lines  were  analyzed  by three- 
color fluorescence  for the expression  of VB2, VB8, and CD3. Shown is 
the V~8/VB2  profile  of  CD3 gated  cells. Doublets  were  excluded  by narrow 
gating on both FSC and CD3. Dead cells were excluded  by PI staining 
during acquisition. 6 x  10  s T cells are displayed. (.4) Polyclonal  V32 + 
cell line. (B) Polyclonal  V38 + cell line. 
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Figure 3.  Distribution of dual fl T cells in the CD45R0  + and R0- 
subsets. PBMC from an adult donor were analyzed by four-color im- 
munofluorescence with anti-V/~2 (mlgM followed by PE-labeled goat 
anti-mouse IgM), V~19 (mlgG1 followed  by biotin-labeled  goat anti-mouse 
IgG1 and APC-SAV), CD3 (mlgG2b FITC conjugated) and CD45R0 
(IgG2a followed  by TXRD-conjugated  goat anti-mouse IgG2a). (.4) Vfl2 
and Vf119 profile of CD3-gated T cells. (B) CD45R0 staining in total 
CD3 + cells. (C) CD45R0 staining ofVfl2 § Vf119  + dual B T cells gated 
in R5 in A. The percentage of cells in the CD45R0  + and R0- subsets 
is indicated. 
In 10 polyclonal cell lines analyzed the frequency of dual B 
T  cells estimated ranged between 0.5 and 3%  (mean  1%). 
Because dual TCR T  cells express  each TCR at a lower 
level compared to single receptor T  cells, it was important 
to ask whether dual/3 T  cells may undergo antigenic selec- 
tion.  We therefore looked at their  distribution  among pe- 
ripheral  blood CD45R0 + and CD45R0-  T cell subsets that 
correspond to memory and naive  populations,  respectively 
(20). As shown by four-color analysis (Fig. 3), the percentage 
of  dual  ~  T  cells  was  actually  slightly  higher  in  the 
CD45R0 + compartment  than  in the CD45R0-  compart- 
ment,  indicating  that  dual receptor T  cells can participate 
in a normal  immune  response. 
In Dual fl T Cells the two Vfl Products Are Part of Two Func- 
tional TCR.  To investigate whether dual fl T  cells could 
be activated through both TCRs, we examined the capacity 
of dual B T  cell clones to proliferate in response to staphy- 
lococcal enterotoxins that selectively engage one or the other 
VB  (21).  Proliferation  of V/32+Vf18 + clones could be in- 
duced by both TSST and SEE which are VB2 and VB8 ligands, 
respectively,  whereas  clones expressing  only Vfl2 or VB8 
proliferated in response to only one of these toxins (data not 
shown). These results confirmed by a yet independent criterion 
the presence of the two Vfls as part of two functional TCRs. 
Discussion 
These results show that  a small proportion  of diploid T 
cells express two Vfls as part of two independent and func- 
tional TCRs. These dual fl T cells are present both in naive 
and memory populations at a frequency of •1%.  Thus, ex- 
pression of two/3 chains is compatible with both thymic and 
peripheral  selection. 
These findings do not question the substantial degree of 
allelic  exclusion at  the fl locus, but rather  the mechanism 
by which this exclusion is achieved.  Since dual/3 T cells are 
generated, it is evident that the extent of B allelic exclusion 
must be determined  only by the asynchrony of rearrange- 
ments at the fl locus, whereas the function of the pre-TCR 
is limited to signaling the presence of "at least one" and not 
of "only one" fi chain.  Accordingly, the production of dual 
B T cells may depend on the occurrence of two simultaneous 
productive rearrangements on both alleles or a rearrangement 
on the second allele before the first B chain product had time 
to  signal  via  pre-TCR.  Alternatively,  it  is  possible  that 
insufficient signaling by the pre-TCR may allow rearrange- 
ment to proceed on the second fl allele. The latter possibility 
is suggested by the fact that the efficiency of allelic exclusion 
is greatly reduced in mice that  carry a dominant  negative 
mutant  lck transgene  (5). 
Since the c~ locus often escapes  allelic  exclusion (2,  14), 
it is likely that up to one third of dual/3 T  cells might ex- 
press two o~ chains as well. T cells with four TCR may thus 
exist, although the selection for preferential pairs may result 
in a quite unbalanced expression of the different TCRs pairs. 
What could be the consequences of the incomplete allelic 
exclusion at the B locus? As previously discussed for T cells 
expressing two ~x chains (14),  the presence of two fl chains 
is compatible with a normal thymic censorship,  since both 
TCRs  can be  simultaneously  tested  for reactivity  to  self- 
antigens  in  the thymus  (22). 
For positive selection,  however, the situation may be differ- 
ent (3).  Since only a small fraction of all possible TCRs is 
selected by a given MHC, it is expected that in a large frac- 
tion of dual receptor T cells only one TCR will have a posi- 
tively selecting specificity.  For this reason it could be argued 
that a nonpositively selecting TCR may be just an inert pas- 
senger, since it will never have the chance to recognize an- 
tigen on self-MHC.  We think  that  this possibility cannot 
be excluded a priori,  since we are not aware of any experi- 
mental evidence indicating that a TCR that is not positively 
selected cannot potentially recognize antigenic peptides bound 
to the nonselecting  MHC molecules. 
In addition,  there is a low but definitive chance that the 
second TCR may be also self-restricted (this chance being 
exactly that of any random TCR to be selected by a partic- 
ular MHC).  Considering the very large number of T  cells 
present in the human repertoire (~1011), the existence of T 
cells with two receptors  that  fit self-MHC is unavoidable. 
Dual receptor T cells may be specific for a broader range 
1590  Dual B T Cells of antigens than cells with a single receptor, which may be 
significant for autoimmunity and alloreactivity. The presence 
of two TCRs on a  single T  cell could pose a problem for 
peripheral tolerance when  this  is based on the inability of 
tissue cells to stimulate  naive T  cells (23,  24).  Thus,  once 
a dual receptor T cell is activated by a foreign antigen recog- 
nized by the first TCK, it may become competent to migrate 
to peripheral tissues and employ the second TCK to attack 
self.  Indeed, both TCKs in dual fl expressing T  cells appear 
to be functional. This type of cross-reactivity would be based 
on a particular somatic combination of two distinct TCR,  s, 
rather than on structural similarity between foreign and self- 
antigens. 
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